- Home
- GDTC vs KFFB Comparison
GDTC vs KFFB Comparison
Compare GDTC & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- KFFB
- Stock Information
- Founded
- GDTC 2018
- KFFB 2005
- Country
- GDTC Singapore
- KFFB United States
- Employees
- GDTC N/A
- KFFB N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- GDTC Health Care
- KFFB Finance
- Exchange
- GDTC Nasdaq
- KFFB Nasdaq
- Market Cap
- GDTC 24.2M
- KFFB 25.9M
- IPO Year
- GDTC 2023
- KFFB 2005
- Fundamental
- Price
- GDTC $2.28
- KFFB $3.81
- Analyst Decision
- GDTC Buy
- KFFB
- Analyst Count
- GDTC 1
- KFFB 0
- Target Price
- GDTC $5.00
- KFFB N/A
- AVG Volume (30 Days)
- GDTC 105.3K
- KFFB 41.3K
- Earning Date
- GDTC 01-01-0001
- KFFB 11-11-2025
- Dividend Yield
- GDTC N/A
- KFFB N/A
- EPS Growth
- GDTC N/A
- KFFB N/A
- EPS
- GDTC N/A
- KFFB 0.02
- Revenue
- GDTC $573,193.00
- KFFB $8,802,000.00
- Revenue This Year
- GDTC $5.37
- KFFB N/A
- Revenue Next Year
- GDTC N/A
- KFFB N/A
- P/E Ratio
- GDTC N/A
- KFFB $187.51
- Revenue Growth
- GDTC 63.03
- KFFB 21.89
- 52 Week Low
- GDTC $1.65
- KFFB $1.96
- 52 Week High
- GDTC $4.05
- KFFB $4.16
- Technical
- Relative Strength Index (RSI)
- GDTC 61.26
- KFFB 54.53
- Support Level
- GDTC $1.95
- KFFB $3.01
- Resistance Level
- GDTC $2.43
- KFFB $3.98
- Average True Range (ATR)
- GDTC 0.18
- KFFB 0.27
- MACD
- GDTC 0.02
- KFFB -0.03
- Stochastic Oscillator
- GDTC 71.00
- KFFB 69.57
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.